Crossmark

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s40035-018-0127-7

Published Online: 2018-09-10

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Zhang, Hua

Ng, Kok Pin

Therriault, Joseph

Kang, Min Su

Pascoal, Tharick A.

Rosa-Neto, Pedro

Gauthier, Serge
Funding

Funding for this research was provided by:

Weston Brain Institute, Canadian Institutes of Health Research (MOP-11-51-31, PR-N)

the Alzheimer's Association (NIRG-12- 92090, NIRP-12-259245)

Fonds de Recherche du Québec - Santé

Clinical key specialist fund, the Department of Neurology, the First Affiliated Hospital of Chongqing Medical University
License Information

Text and Data Mining valid from 2018-09-10
More Information

Article History

Received: 29 May 2018

Accepted: 20 August 2018

First Online: 10 September 2018

Ethics approval and consent to participate

: The ADNI study was approved by the Institutional Review boards of all of the participating institutions. All participants provided informed consent at each site.

: Not applicable.

: The authors declare that they have no competing interests.